[go: up one dir, main page]

WO2011141685A3 - Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof - Google Patents

Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof Download PDF

Info

Publication number
WO2011141685A3
WO2011141685A3 PCT/FR2011/051082 FR2011051082W WO2011141685A3 WO 2011141685 A3 WO2011141685 A3 WO 2011141685A3 FR 2011051082 W FR2011051082 W FR 2011051082W WO 2011141685 A3 WO2011141685 A3 WO 2011141685A3
Authority
WO
WIPO (PCT)
Prior art keywords
constituents
nasal compositions
cocoyl proline
systemic nasal
cocoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2011/051082
Other languages
French (fr)
Other versions
WO2011141685A2 (en
Inventor
Jean-Luc Pougnas
Olivier Broussaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYSICA PHARMA Sas
Original Assignee
PHYSICA PHARMA Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYSICA PHARMA Sas filed Critical PHYSICA PHARMA Sas
Publication of WO2011141685A2 publication Critical patent/WO2011141685A2/en
Publication of WO2011141685A3 publication Critical patent/WO2011141685A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a pharmaceutical composition that can be administered nasally, comprising cocoyl proline or at least one of its constituents and a therapeutic agent. The invention also relates to the production method thereof and uses of same.
PCT/FR2011/051082 2010-05-14 2011-05-13 Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof Ceased WO2011141685A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1002068A FR2959936B1 (en) 2010-05-14 2010-05-14 NASAL COMPOSITION WITH A SYSTEMIC VIEW BASED ON COCOYL PROLINE OR AT LEAST ONE OF ITS COMPONENTS
FR10/02068 2010-05-14

Publications (2)

Publication Number Publication Date
WO2011141685A2 WO2011141685A2 (en) 2011-11-17
WO2011141685A3 true WO2011141685A3 (en) 2012-08-02

Family

ID=43413662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2011/051082 Ceased WO2011141685A2 (en) 2010-05-14 2011-05-13 Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof

Country Status (2)

Country Link
FR (1) FR2959936B1 (en)
WO (1) WO2011141685A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2868058C (en) 2012-03-30 2019-12-17 Givaudan S.A. N-acylated methionine derivatives as food flavouring compounds
CN104219963B (en) * 2012-03-30 2018-08-14 奇华顿股份有限公司 As food fragrance compound N- sulphonyl-aminos acid derivative, include their powder composition
US10856563B2 (en) 2012-03-30 2020-12-08 Givaudan S.A. N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
CN104219965B (en) 2012-03-30 2018-10-12 奇华顿股份有限公司 N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavoring compounds
CA2867300C (en) * 2012-03-30 2019-08-20 Givaudan S.A. N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
CN104219964B (en) * 2012-03-30 2016-09-21 奇华顿股份有限公司 N-acylproline derivatives as food flavoring compounds
CA2867329C (en) 2012-03-30 2020-03-10 Givaudan S.A. N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
EP3057446B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
CN105636457B (en) 2013-10-02 2020-03-10 奇华顿股份有限公司 Organic compounds with taste-improving properties
US10674755B2 (en) 2013-10-02 2020-06-09 Givaudan S.A. Organic Compounds
CN105592719B (en) 2013-10-02 2020-03-10 奇华顿股份有限公司 organic compounds
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
CN105592720B (en) 2013-10-02 2020-07-07 奇华顿股份有限公司 Organic compounds with taste-improving properties
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
EP3052472B1 (en) 2013-10-02 2019-02-27 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
FR2686511A1 (en) * 1992-01-28 1993-07-30 Ir2M Pharmaceutical composition containing combinations of vanadium and/or niobium with amino acids or amino acid derivatives
WO2002076506A1 (en) * 2001-03-28 2002-10-03 Physica S.A.R.L. Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
FR2834215A1 (en) * 2001-12-27 2003-07-04 Physica AMPHIPHILIC COMPOUNDS FOR PHARMACEUTICAL OR COSMETIC USE
US20040248846A1 (en) * 2003-04-22 2004-12-09 Nastech Pharmaceutical Company Inc. Intranasal administration of triptans
FR2935378A1 (en) * 2008-08-29 2010-03-05 Seppic Sa USE OF N-ACYL AMINO ACIDS AS COSMETIC AND PHARMACEUTICAL ACTIVE INGREDIENTS CAPABLE OF REDUCING THE INFLAMMATORY CONDITION OF SENESCENT REPLICATIVE FIBROBLASTS FROM HUMAN ADULT DERMAS; ANTI-AGE COSMETIC COMPOSITIONS
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
FR2686511A1 (en) * 1992-01-28 1993-07-30 Ir2M Pharmaceutical composition containing combinations of vanadium and/or niobium with amino acids or amino acid derivatives
WO2002076506A1 (en) * 2001-03-28 2002-10-03 Physica S.A.R.L. Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
FR2834215A1 (en) * 2001-12-27 2003-07-04 Physica AMPHIPHILIC COMPOUNDS FOR PHARMACEUTICAL OR COSMETIC USE
US20040248846A1 (en) * 2003-04-22 2004-12-09 Nastech Pharmaceutical Company Inc. Intranasal administration of triptans
FR2935378A1 (en) * 2008-08-29 2010-03-05 Seppic Sa USE OF N-ACYL AMINO ACIDS AS COSMETIC AND PHARMACEUTICAL ACTIVE INGREDIENTS CAPABLE OF REDUCING THE INFLAMMATORY CONDITION OF SENESCENT REPLICATIVE FIBROBLASTS FROM HUMAN ADULT DERMAS; ANTI-AGE COSMETIC COMPOSITIONS
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin

Also Published As

Publication number Publication date
WO2011141685A2 (en) 2011-11-17
FR2959936A1 (en) 2011-11-18
FR2959936B1 (en) 2012-08-03

Similar Documents

Publication Publication Date Title
WO2011141685A3 (en) Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
IL275854A (en) Pharmaceutical composition and administration thereof
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2012174158A3 (en) Administration of benzodiazepine
IL233677A (en) Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments
WO2011103202A3 (en) Androgen receptor modulators and uses thereof
WO2010054113A3 (en) Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
WO2012037410A3 (en) Estrogen receptor modulators and uses thereof
WO2011156518A3 (en) Estrogen receptor modulators and uses thereof
WO2011086093A3 (en) Pharmaceutical compositions for oral administration of insulin peptides
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2010037059A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2011060049A3 (en) Spiro-oxindole mdm2 antagonists
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
WO2012075383A3 (en) Bromodomain inhibitors and uses thereof
IL222268A (en) Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
ZA201008379B (en) Glucocorticoid mimetics,methods of making them,pharmaceutical compositions,and uses thereof
WO2009108720A3 (en) Antagonists of prostaglandin d2 receptors
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
IL211842A (en) Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis
WO2010057118A3 (en) Heterocyclic antagonists of prostaglandin d2 receptors
WO2012135619A3 (en) Intranasal benzodiazepine pharmaceutical compositions
WO2012021715A3 (en) Stable formulations of linaclotide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11725487

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11725487

Country of ref document: EP

Kind code of ref document: A2